Avanos Medical (AVNS) director awarded 12,003 cash-settled RSUs

Rhea-AI Filing Summary

BLACKFORD GARY reported acquisition or exercise transactions in this Form 4 filing.

AVANOS MEDICAL, INC. director Gary Blackford received a grant of 12,003 restricted share units on May 8, 2026. Each unit represents a contingent right to a cash payment equal to the value of one share of Avanos common stock.

The 12,003 restricted share units were issued to replace units originally granted on January 2, 2025 and will vest when Blackford terminates his service on the company’s Board of Directors.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider BLACKFORD GARY

Role null

Type	Security	Shares	Price	Value
Grant/Award	Restricted Share Units	12,003	$0.00	--

Holdings After Transaction: Restricted Share Units — 12,003 shares (Direct, null)

Footnotes (1)

1. Represents restricted share units issued to the Reporting Person on May 8, 2026. Each restricted share unit represents a contingent right to receive a cash payment equal to the value of one share of the Issuer's common stock. The restricted share units were issued to replace the restricted share units issued to the Reporting Person on January 2, 2025. The restricted share units vest on the date the Reporting Person terminates service on the Issuer's Board of Directors.

Key Figures

RSUs granted: 12,003 restricted share units Settlement type: Cash equal to one common share per unit RSUs outstanding after grant: 12,003 restricted share units +1 more

4 metrics

RSUs granted 12,003 restricted share units Grant to director on May 8, 2026

Settlement type Cash equal to one common share per unit Each RSU tracks Avanos common stock value

RSUs outstanding after grant 12,003 restricted share units Total units held following the reported transaction

Original grant date replaced January 2, 2025 New RSUs replace prior RSUs granted on this date

Key Terms

Restricted Share Units, contingent right, cash payment, vest, +1 more

5 terms

Restricted Share Units financial

"Represents restricted share units issued to the Reporting Person on May 8, 2026."

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

contingent right financial

"Each restricted share unit represents a contingent right to receive a cash payment"

cash payment financial

"a contingent right to receive a cash payment equal to the value of one share"

vest financial

"The restricted share units vest on the date the Reporting Person terminates service"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Board of Directors financial

"terminates service on the Issuer's Board of Directors."

The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BLACKFORD GARY

(Last) (First) (Middle)

5405 WINDWARD PARKWAY

(Street)

ALPHARETTA GEORGIA 30004

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AVANOS MEDICAL, INC. [ AVNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Units	(1)	05/08/2026		A		12,003		(2)	(2)	Common Stock	12,003	$0	12,003	D

Explanation of Responses:

1. Represents restricted share units issued to the Reporting Person on May 8, 2026. Each restricted share unit represents a contingent right to receive a cash payment equal to the value of one share of the Issuer's common stock. The restricted share units were issued to replace the restricted share units issued to the Reporting Person on January 2, 2025.

2. The restricted share units vest on the date the Reporting Person terminates service on the Issuer's Board of Directors.

Remarks:

	/s/ John Fischer, as attorney-in-fact for Gary Blackford	05/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did AVNS director Gary Blackford report on this Form 4?

Gary Blackford reported receiving 12,003 restricted share units from Avanos Medical. These units were granted on May 8, 2026 as part of his director compensation and replace an earlier grant made on January 2, 2025.

How many restricted share units did AVNS grant to director Gary Blackford?

Avanos Medical granted Gary Blackford 12,003 restricted share units. This entire amount remains outstanding after the transaction, giving him 12,003 units tied to the company’s common stock value through cash-settled awards.

How are Gary Blackford’s AVNS restricted share units settled?

Each restricted share unit entitles Gary Blackford to a cash payment equal to the value of one Avanos common share. The award is therefore cash-settled, tracking the company’s share price rather than delivering actual shares.

When do Gary Blackford’s AVNS restricted share units vest?

The restricted share units vest when Gary Blackford terminates his service on Avanos Medical’s Board of Directors. This means the award is tied to the duration of his board service rather than a fixed calendar vesting schedule.

Why did Avanos Medical replace Gary Blackford’s earlier restricted share units grant?

The 12,003 restricted share units issued on May 8, 2026 were granted to replace restricted share units originally issued on January 2, 2025. The filing states this replacement directly, without adding details on any other changes to terms.